Member Info for solstace

Next step submission of data to MHRA for emergency use. In full production and being prescribed ready for the winter surge.......

https://www.outsourcing-pharma.com/Article/2014/03/20/UK-MHRA-scheme-will-allow-compassionate-use-of-unlicensed-drugs

No mention of selling AZD1656! I feel there will be a deal struck with AZ, cash up front to cover monies already spent + X millions and licencing and royalty agreement. Bringing recurring annual revenue for all parties involved.
Going to be big imop GLA DYOR :-)

https://www.clinicaltrials.gov/ct2/show/NCT04516759?term=Arcadia&cond=COVID-19&draw=2&rank=1

And warrants alone are holding this down. Today+Tomorrow will clear them and with press over the wkend I predict a big blue day Monday! GLA :-)

Vast majority of big delayed trades will be warrants. Once cleared this will rise SIMPLES

Check again in the morning bet there's some monster trades pop up!

Fast tracked this trial! Worth noting :-)

The fundraise mentioned is St george Street. Vela are not raising they have 8% if they wish to invest more for X % increase they have £2m in the bank to do so.
Read the RNS but more importantly understand it before spouting nonsense! Cheers

Yes you can :-)

Dshox keep up it has been RNS'd just not showing on LSE lol

Once done this will fly imop! With todays volume likey be done ready for tomorrow/Monday at the latest :-)

VELA DO Not need funding. Sgs may need but not VELA

You might have noticed there is no longer mention of a "sale" of AZD1656 from what I read licence/partner because its massive year on year recurring revenue!

A treatment for All!

The data from ARCADIA supports continued investigation of AZD1656 for the treatment of patients with COVID-19, with or without diabetes, in future clinical trials.

Who are the major shareholders at Igraine (king)

The only investment listed on Igraines website is Excalibur. This has been set up as a cash cow for the directors of Excalibur imop

Has been set up by the top Execs at Excalibur and its only investment is 2% of AZD1656.................Retirement fund boys??

Igraine has invested in Excalibur Medicines Ltd (“EML”), a subsidiary of Excalibur Healthcare Services Ltd. EML has secured exclusive rights to and owns the COVID-19 patents on a drug, AZD1656, which is being developed as a potential therapeutic for diabetics suffering from COVID-19.

As there are very few new therapeutics in development for COVID-19 and associated virally transmitted diseases (most research is in combining existing treatments) this has the potential to be highly attractive to big pharma and biotech buyers. Further, if the trials are successful, it is likely the drug will be effective for the general population in COVID -19 and in other respiratory diseases.

I like the Igraine 2% acquisition a couple of months ago.

Top chaps are from Excalibur so the purchase tells me all I need to know!

https://igraineplc.com/

Big buyer accumulating in the background................ :-)

consistently over 0.10, slight pull back happening ready for the afternoon surge.......Close around 0.12-0.15?????